Skip to content
2000
image of Ubiquitination-based Classification and a Prognostic Signature Identify the Role of TRIM21 in Sarcoma Progression

Abstract

Introduction

Sarcomas are heterogeneous mesenchymal tumors with poor responses to systemic therapies. Ubiquitination is a post-translational modification that regulates various physiological processes and cancer growth.

Methods

We analyzed the transcriptomic data of 256 sarcoma patients from The Cancer Genome Atlas (TCGA) to define the network and prognostic value of predefined ubiquitination-related genes and performed subgroup analyses. Additionally, the role of TRIM21 in sarcoma progression was explored using cellular experiments.

Results

We identified two ubiquitination-related clusters, and patients in the two clusters were characterized by different survival outcomes, enriched pathways, and characteristics of the tumor microenvironment. A ubiquitination-related signature involving LRRC41, RNF125, TRIM21, and UBE3D was identified to predict prognoses. The signature was associated with patient prognoses in the public sarcoma cohorts and our independent cohort. Immunohistochemistry analyses revealed that the risk score and CD8 could distinguish patients with different survival outcomes in our cohort. Mechanistically, different risk groups were also characterized by distinct enriched pathways and characteristics of the tumor microenvironment. Cellular experiments revealed that TRIM21 overexpression could suppress tumor progression in sarcomas.

Discussion

This study provided a novel classification for sarcoma patients based on expressions of ubiquitination-related genes. The classification and the prognostic model may facilitate the understanding of sarcoma pathogenesis, the prediction of prognosis and immunotherapy response for sarcoma patients. Meanwhile, it was confirmed that TRIM21 suppressed sarcoma progression and identified it as a potential target for therapeutic interventions.

Conclusion

The classification and signature stratify sarcoma patients for prognosis and immunotherapy response, with TRIM21 representing a promising therapeutic target.

© 2026 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673388379251113061745
2026-01-15
2026-02-26
Loading full text...

Full text loading...

/deliver/fulltext/cmc/10.2174/0109298673388379251113061745/BMS-CMC-2025-HT137-6012-12.html?itemId=/content/journals/cmc/10.2174/0109298673388379251113061745&mimeType=html&fmt=ahah

References

  1. Kret Z.S. Sweder R.J. Pollock R. Tinoco G. Potential mechanisms for immunotherapy resistance in adult soft-tissue sarcoma. Target. Oncol. 2025 20 3 485 502 10.1007/s11523‑025‑01145‑5 40289241
    [Google Scholar]
  2. Spalato-Ceruso M. Ghazzi N.E. Italiano A. New strategies in soft tissue sarcoma treatment. J. Hematol. Oncol. 2024 17 1 76 10.1186/s13045‑024‑01580‑3 39218932
    [Google Scholar]
  3. Riskjell A.I. Mäkinen V.N. Sandfeld-Paulsen B. Aggerholm-Pedersen N. Targeted treatment of soft-tissue sarcoma. J. Pers. Med. 2023 13 5 730 10.3390/jpm13050730 37240900
    [Google Scholar]
  4. Yang D. Yang C. Huang L. Guan M. Song C. Role of ubiquitination-driven metabolisms in oncogenesis and cancer therapy. Semin. Cancer Biol. 2025 110 17 35 10.1016/j.semcancer.2025.02.004 39929409
    [Google Scholar]
  5. Parashar S. Kaushik A. Ambasta R.K. Kumar P. E2 conjugating enzymes: A silent but crucial player in ubiquitin biology. Ageing Res. Rev. 2025 108 102740 10.1016/j.arr.2025.102740 40194666
    [Google Scholar]
  6. Ren J. Yu P. Liu S. Li R. Niu X. Chen Y. Zhang Z. Zhou F. Zhang L. Deubiquitylating enzymes in cancer and immunity. Adv. Sci. 2023 10 36 2303807 10.1002/advs.202303807 37888853
    [Google Scholar]
  7. Jiang Y. Dai A. Huang Y. Li H. Cui J. Yang H. Si L. Jiao T. Ren Z. Zhang Z. Mou S. Zhu H. Guo W. Huang Q. Li Y. Xue M. Jiang J. Wang F. Li L. Zhong Q. Wang K. Liu B. Wang J. Fan G. Guo J. Chen L. Workman C.J. Shen Z. Kong Y. Vignali D.A.A. Xu C. Wang H. Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifs. Cell 2025 188 9 2354 2371.e18 10.1016/j.cell.2025.02.014 40101708
    [Google Scholar]
  8. Fan X. Dai Y. Mo C. Li H. Luan X. Wang B. Yang J. Jiao G. Lu X. Chen Z. Liao Y. Qu L. Yang H. Lou C. Liu C. Li Z. TRIM21 promotes tumor growth and gemcitabine resistance in pancreatic cancer by inhibiting EPHX1‐mediated arachidonic acid metabolism. Adv. Sci. 2025 12 8 2413674 10.1002/advs.202413674 39739616
    [Google Scholar]
  9. Fan Y. Wang Y. Dan W. Zhang Y. Nie L. Ma Z. Zhuang Y. Liu B. Li M. Liu T. Wang Z. Ye L. Wei Y. Lei Y. Guo C. An J. Wang C. Zhang Y. Zeng J. Wei W. Gan B. Li L. PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer. Nat. Cell Biol. 2025 27 4 641 653 10.1038/s41556‑025‑01610‑3 40033101
    [Google Scholar]
  10. Zhou J. Xu Y. Lin S. Guo Y. Deng W. Zhang Y. Guo A. Xue Y. iUUCD 2.0: An update with rich annotations for ubiquitin and ubiquitin-like conjugations. Nucleic Acids Res. 2018 46 D1 D447 D453 10.1093/nar/gkx1041 29106644
    [Google Scholar]
  11. Song K.J. Choi S. Kim K. Hwang H.S. Chang E. Park J.S. Shim S.B. Choi S. Heo Y.J. An W.J. Yang D.Y. Cho K.C. Ji W. Choi C.M. Lee J.C. Kim H. Yoo J. Ahn H.S. Lee G.H. Hwa C. Kim S. Kim K. Kim M.S. Paek E. Na S. Jang S.J. An J.Y. Kim K.P. Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment. Nat. Commun. 2024 15 1 10164 10.1038/s41467‑024‑54434‑4 39580524
    [Google Scholar]
  12. Liberzon A. Birger C. Thorvaldsdóttir H. Ghandi M. Mesirov J.P. Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015 1 6 417 425 10.1016/j.cels.2015.12.004 26771021
    [Google Scholar]
  13. Lin W. Wang X. Xu Z. Wang Z. Liu T. Cao Z. Feng X. Gao Y. He J. Identification and validation of cellular senescence patterns to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma. Cancer Cell Int. 2021 21 1 652 10.1186/s12935‑021‑02358‑0 34872577
    [Google Scholar]
  14. Thorsson V. Gibbs D.L. Brown S.D. Wolf D. Bortone D.S. Ou Yang T.H. Porta-Pardo E. Gao G.F. Plaisier C.L. Eddy J.A. Ziv E. Culhane A.C. Paull E.O. Sivakumar I.K.A. Gentles A.J. Malhotra R. Farshidfar F. Colaprico A. Parker J.S. Mose L.E. Vo N.S. Liu J. Liu Y. Rader J. Dhankani V. Reynolds S.M. Bowlby R. Califano A. Cherniack A.D. Anastassiou D. Bedognetti D. Mokrab Y. Newman A.M. Rao A. Chen K. Krasnitz A. Hu H. Malta T.M. Noushmehr H. Pedamallu C.S. Bullman S. Ojesina A.I. Lamb A. Zhou W. Shen H. Choueiri T.K. Weinstein J.N. Guinney J. Saltz J. Holt R.A. Rabkin C.S. Lazar A.J. Serody J.S. Demicco E.G. Disis M.L. Vincent B.G. Shmulevich I. Caesar-Johnson S.J. Demchok J.A. Felau I. Kasapi M. Ferguson M.L. Hutter C.M. Sofia H.J. Tarnuzzer R. Wang Z. Yang L. Zenklusen J.C. Zhang J.J. Chudamani S. Liu J. Lolla L. Naresh R. Pihl T. Sun Q. Wan Y. Wu Y. Cho J. DeFreitas T. Frazer S. Gehlenborg N. Getz G. Heiman D.I. Kim J. Lawrence M.S. Lin P. Meier S. Noble M.S. Saksena G. Voet D. Zhang H. Bernard B. Chambwe N. Dhankani V. Knijnenburg T. Kramer R. Leinonen K. Liu Y. Miller M. Reynolds S. Shmulevich I. Thorsson V. Zhang W. Akbani R. Broom B.M. Hegde A.M. Ju Z. Kanchi R.S. Korkut A. Li J. Liang H. Ling S. Liu W. Lu Y. Mills G.B. Ng K-S. Rao A. Ryan M. Wang J. Weinstein J.N. Zhang J. Abeshouse A. Armenia J. Chakravarty D. Chatila W.K. de Bruijn I. Gao J. Gross B.E. Heins Z.J. Kundra R. La K. Ladanyi M. Luna A. Nissan M.G. Ochoa A. Phillips S.M. Reznik E. Sanchez-Vega F. Sander C. Schultz N. Sheridan R. Sumer S.O. Sun Y. Taylor B.S. Wang J. Zhang H. Anur P. Peto M. Spellman P. Benz C. Stuart J.M. Wong C.K. Yau C. Hayes D.N. Parker J.S. Wilkerson M.D. Ally A. Balasundaram M. Bowlby R. Brooks D. Carlsen R. Chuah E. Dhalla N. Holt R. Jones S.J.M. Kasaian K. Lee D. Ma Y. Marra M.A. Mayo M. Moore R.A. Mungall A.J. Mungall K. Robertson A.G. Sadeghi S. Schein J.E. Sipahimalani P. Tam A. Thiessen N. Tse K. Wong T. Berger A.C. Beroukhim R. Cherniack A.D. Cibulskis C. Gabriel S.B. Gao G.F. Ha G. Meyerson M. Schumacher S.E. Shih J. Kucherlapati M.H. Kucherlapati R.S. Baylin S. Cope L. Danilova L. Bootwalla M.S. Lai P.H. Maglinte D.T. Van Den Berg D.J. Weisenberger D.J. Auman J.T. Balu S. Bodenheimer T. Fan C. Hoadley K.A. Hoyle A.P. Jefferys S.R. Jones C.D. Meng S. Mieczkowski P.A. Mose L.E. Perou A.H. Perou C.M. Roach J. Shi Y. Simons J.V. Skelly T. Soloway M.G. Tan D. Veluvolu U. Fan H. Hinoue T. Laird P.W. Shen H. Zhou W. Bellair M. Chang K. Covington K. Creighton C.J. Dinh H. Doddapaneni H.V. Donehower L.A. Drummond J. Gibbs R.A. Glenn R. Hale W. Han Y. Hu J. Korchina V. Lee S. Lewis L. Li W. Liu X. Morgan M. Morton D. Muzny D. Santibanez J. Sheth M. Shinbrot E. Wang L. Wang M. Wheeler D.A. Xi L. Zhao F. Hess J. Appelbaum E.L. Bailey M. Cordes M.G. Ding L. Fronick C.C. Fulton L.A. Fulton R.S. Kandoth C. Mardis E.R. McLellan M.D. Miller C.A. Schmidt H.K. Wilson R.K. Crain D. Curley E. Gardner J. Lau K. Mallery D. Morris S. Paulauskis J. Penny R. Shelton C. Shelton T. Sherman M. Thompson E. Yena P. Bowen J. Gastier-Foster J.M. Gerken M. Leraas K.M. Lichtenberg T.M. Ramirez N.C. Wise L. Zmuda E. Corcoran N. Costello T. Hovens C. Carvalho A.L. de Carvalho A.C. Fregnani J.H. Longatto-Filho A. Reis R.M. Scapulatempo-Neto C. Silveira H.C.S. Vidal D.O. Burnette A. Eschbacher J. Hermes B. Noss A. Singh R. Anderson M.L. Castro P.D. Ittmann M. Huntsman D. Kohl B. Le X. Thorp R. Andry C. Duffy E.R. Lyadov V. Paklina O. Setdikova G. Shabunin A. Tavobilov M. McPherson C. Warnick R. Berkowitz R. Cramer D. Feltmate C. Horowitz N. Kibel A. Muto M. Raut C.P. Malykh A. Barnholtz-Sloan J.S. Barrett W. Devine K. Fulop J. Ostrom Q.T. Shimmel K. Wolinsky Y. Sloan A.E. De Rose A. Giuliante F. Goodman M. Karlan B.Y. Hagedorn C.H. Eckman J. Harr J. Myers J. Tucker K. Zach L.A. Deyarmin B. Hu H. Kvecher L. Larson C. Mural R.J. Somiari S. Vicha A. Zelinka T. Bennett J. Iacocca M. Rabeno B. Swanson P. Latour M. Lacombe L. Têtu B. Bergeron A. McGraw M. Staugaitis S.M. Chabot J. Hibshoosh H. Sepulveda A. Su T. Wang T. Potapova O. Voronina O. Desjardins L. Mariani O. Roman-Roman S. Sastre X. Stern M-H. Cheng F. Signoretti S. Berchuck A. Bigner D. Lipp E. Marks J. McCall S. McLendon R. Secord A. Sharp A. Behera M. Brat D.J. Chen A. Delman K. Force S. Khuri F. Magliocca K. Maithel S. Olson J.J. Owonikoko T. Pickens A. Ramalingam S. Shin D.M. Sica G. Van Meir E.G. Zhang H. Eijckenboom W. Gillis A. Korpershoek E. Looijenga L. Oosterhuis W. Stoop H. van Kessel K.E. Zwarthoff E.C. Calatozzolo C. Cuppini L. Cuzzubbo S. DiMeco F. Finocchiaro G. Mattei L. Perin A. Pollo B. Chen C. Houck J. Lohavanichbutr P. Hartmann A. Stoehr C. Stoehr R. Taubert H. Wach S. Wullich B. Kycler W. Murawa D. Wiznerowicz M. Chung K. Edenfield W.J. Martin J. Baudin E. Bubley G. Bueno R. De Rienzo A. Richards W.G. Kalkanis S. Mikkelsen T. Noushmehr H. Scarpace L. Girard N. Aymerich M. Campo E. Giné E. Guillermo A.L. Van Bang N. Hanh P.T. Phu B.D. Tang Y. Colman H. Evason K. Dottino P.R. Martignetti J.A. Gabra H. Juhl H. Akeredolu T. Stepa S. Hoon D. Ahn K. Kang K.J. Beuschlein F. Breggia A. Birrer M. Bell D. Borad M. Bryce A.H. Castle E. Chandan V. Cheville J. Copland J.A. Farnell M. Flotte T. Giama N. Ho T. Kendrick M. Kocher J-P. Kopp K. Moser C. Nagorney D. O’Brien D. O’Neill B.P. Patel T. Petersen G. Que F. Rivera M. Roberts L. Smallridge R. Smyrk T. Stanton M. Thompson R.H. Torbenson M. Yang J.D. Zhang L. Brimo F. Ajani J.A. Gonzalez A.M.A. Behrens C. Bondaruk J. Broaddus R. Czerniak B. Esmaeli B. Fujimoto J. Gershenwald J. Guo C. Lazar A.J. Logothetis C. Meric-Bernstam F. Moran C. Ramondetta L. Rice D. Sood A. Tamboli P. Thompson T. Troncoso P. Tsao A. Wistuba I. Carter C. Haydu L. Hersey P. Jakrot V. Kakavand H. Kefford R. Lee K. Long G. Mann G. Quinn M. Saw R. Scolyer R. Shannon K. Spillane A. Stretch Synott M. Thompson J. Wilmott J. Al-Ahmadie H. Chan T.A. Ghossein R. Gopalan A. Levine D.A. Reuter V. Singer S. Singh B. Tien N.V. Broudy T. Mirsaidi C. Nair P. Drwiega P. Miller J. Smith J. Zaren H. Park J-W. Hung N.P. Kebebew E. Linehan W.M. Metwalli A.R. Pacak K. Pinto P.A. Schiffman M. Schmidt L.S. Vocke C.D. Wentzensen N. Worrell R. Yang H. Moncrieff M. Goparaju C. Melamed J. Pass H. Botnariuc N. Caraman I. Cernat M. Chemencedji I. Clipca A. Doruc S. Gorincioi G. Mura S. Pirtac M. Stancul I. Tcaciuc D. Albert M. Alexopoulou I. Arnaout A. Bartlett J. Engel J. Gilbert S. Parfitt J. Sekhon H. Thomas G. Rassl D.M. Rintoul R.C. Bifulco C. Tamakawa R. Urba W. Hayward N. Timmers H. Antenucci A. Facciolo F. Grazi G. Marino M. Merola R. de Krijger R. Gimenez-Roqueplo A-P. Piché A. Chevalier S. McKercher G. Birsoy K. Barnett G. Brewer C. Farver C. Naska T. Pennell N.A. Raymond D. Schilero C. Smolenski K. Williams F. Morrison C. Borgia J.A. Liptay M.J. Pool M. Seder C.W. Junker K. Omberg L. Dinkin M. Manikhas G. Alvaro D. Bragazzi M.C. Cardinale V. Carpino G. Gaudio E. Chesla D. Cottingham S. Dubina M. Moiseenko F. Dhanasekaran R. Becker K-F. Janssen K-P. Slotta-Huspenina J. Abdel-Rahman M.H. Aziz D. Bell S. Cebulla C.M. Davis A. Duell R. Elder J.B. Hilty J. Kumar B. Lang J. Lehman N.L. Mandt R. Nguyen P. Pilarski R. Rai K. Schoenfield L. Senecal K. Wakely P. Hansen P. Lechan R. Powers J. Tischler A. Grizzle W.E. Sexton K.C. Kastl A. Henderson J. Porten S. Waldmann J. Fassnacht M. Asa S.L. Schadendorf D. Couce M. Graefen M. Huland H. Sauter G. Schlomm T. Simon R. Tennstedt P. Olabode O. Nelson M. Bathe O. Carroll P.R. Chan J.M. Disaia P. Glenn P. Kelley R.K. Landen C.N. Phillips J. Prados M. Simko J. Smith-McCune K. VandenBerg S. Roggin K. Fehrenbach A. Kendler A. Sifri S. Steele R. Jimeno A. Carey F. Forgie I. Mannelli M. Carney M. Hernandez B. Campos B. Herold-Mende C. Jungk C. Unterberg A. von Deimling A. Bossler A. Galbraith J. Jacobus L. Knudson M. Knutson T. Ma D. Milhem M. Sigmund R. Godwin A.K. Madan R. Rosenthal H.G. Adebamowo C. Adebamowo S.N. Boussioutas A. Beer D. Giordano T. Mes-Masson A-M. Saad F. Bocklage T. Landrum L. Mannel R. Moore K. Moxley K. Postier R. Walker J. Zuna R. Feldman M. Valdivieso F. Dhir R. Luketich J. Pinero E.M.M. Quintero-Aguilo M. Carlotti C.G. Jr Dos Santos J.S. Kemp R. Sankarankuty A. Tirapelli D. Catto J. Agnew K. Swisher E. Creaney J. Robinson B. Shelley C.S. Godwin E.M. Kendall S. Shipman C. Bradford C. Carey T. Haddad A. Moyer J. Peterson L. Prince M. Rozek L. Wolf G. Bowman R. Fong K.M. Yang I. Korst R. Rathmell W.K. Fantacone-Campbell J.L. Hooke J.A. Kovatich A.J. Shriver C.D. DiPersio J. Drake B. Govindan R. Heath S. Ley T. Van Tine B. Westervelt P. Rubin M.A. Lee J.I. Aredes N.D. Mariamidze A. The immune landscape of cancer. Immunity 2018 48 4 812 830.e14 10.1016/j.immuni.2018.03.023 29628290
    [Google Scholar]
  15. Li T. Fan J. Wang B. Traugh N. Chen Q. Liu J.S. Li B. Liu X.S. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017 77 21 e108 e110 10.1158/0008‑5472.CAN‑17‑0307 29092952
    [Google Scholar]
  16. Li T. Fu J. Zeng Z. Cohen D. Li J. Chen Q. Li B. Liu X.S. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020 48 W1 W509 W514 10.1093/nar/gkaa407 32442275
    [Google Scholar]
  17. Wang W. Shao F. Yang X. Wang J. Zhu R. Yang Y. Zhao G. Guo D. Sun Y. Wang J. Xue Q. Gao S. Gao Y. He J. Lu Z. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding. Nat. Commun. 2021 12 1 3803 10.1038/s41467‑021‑23501‑5 34155197
    [Google Scholar]
  18. Zhang L. Yang Y. Lin W. Shao F. Gao Y. He J. Complement-related molecular classification and a gene signature for lung adenocarcinoma. Exp. Hematol. Oncol. 2023 12 1 22 10.1186/s40164‑023‑00388‑0 36810204
    [Google Scholar]
  19. Hong Y. Zhang L. Lin W. Yang Y. Cao Z. Feng X. Yu Z. Gao Y. Transcriptome sequencing unveils a molecular-stratification-predicting prognosis of sarcoma associated with lipid metabolism. Int. J. Mol. Sci. 2024 25 3 1643 10.3390/ijms25031643 38338920
    [Google Scholar]
  20. Chen L. Zhang L. He H. Shao F. Yu Z. Gao Y. He J. Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation. Oncogene 2024 43 26 2025 2037 10.1038/s41388‑024‑03047‑8 38744954
    [Google Scholar]
  21. Shen Y Ma Z Wang H Chen Y Fang Y Apetoh L Zhang G He F Xie S Guo J Alcaligenes faecalis induces intestinal T helper-17 cells by enhancing Rorc transcription through E3 ligase Trim21-mediated Fbxw7 degradation. Immunity 2025 58 6 1469 1483.e8 10.1016/j.immuni.2025.03.008 40215968
    [Google Scholar]
  22. Shi J. Zhang Z. Chen H.Y. Yao Y. Ke S. Yu K. Shi J. Xiao X. He C. Xiang B. Sun Y. Gao M. Xing X. Yu H. Wang X. Yuan W.C. Budiarto B.R. Chen S.Y. Zhang T. Lee Y.R. Zhu H. Zhang J. Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy. Mol. Ther. 2025 33 3 1073 1090 10.1016/j.ymthe.2025.01.047 39905727
    [Google Scholar]
  23. Cao M. Shao Z. Qian X. Chen M. Deng C. Chen X. Tang T. Zhang K. Chu S. Zheng J. Bai J. Li Z. TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression. Cell Death Dis. 2025 16 1 56 10.1038/s41419‑025‑07383‑9 39890802
    [Google Scholar]
  24. Sbaraglia M. Bellan E. Dei Tos A.P. The 2020 WHO classification of soft tissue tumours: News and perspectives. Pathologica 2020 113 2 70 84 10.32074/1591‑951X‑213 33179614
    [Google Scholar]
  25. Pankova V. Krasny L. Kerrison W. Tam Y.B. Chadha M. Burns J. Wilding C.P. Chen L. Chowdhury A. Perkins E. Lee A.T.J. Howell L. Guljar N. Sisley K. Fisher C. Chudasama P. Thway K. Jones R.L. Huang P.H. Clinical implications and molecular features of extracellular matrix networks in soft tissue sarcomas. Clin. Cancer Res. 2024 30 15 3229 3242 10.1158/1078‑0432.CCR‑23‑3960 38810090
    [Google Scholar]
  26. Italiano A. Bessede A. Pulido M. Bompas E. Piperno-Neumann S. Chevreau C. Penel N. Bertucci F. Toulmonde M. Bellera C. Guegan J.P. Rey C. Sautès-Fridman C. Bougoüin A. Cantarel C. Kind M. Spalato M. Dadone-Montaudie B. Le Loarer F. Blay J.Y. Fridman W.H. Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: A phase 2 PEMBROSARC trial cohort. Nat. Med. 2022 28 6 1199 1206 10.1038/s41591‑022‑01821‑3 35618839
    [Google Scholar]
  27. Zhang M. Liu C. Tu J. Tang M. Ashrafizadeh M. Nabavi N. Sethi G. Zhao P. Liu S. Advances in cancer immunotherapy: Historical perspectives, current developments, and future directions. Mol. Cancer 2025 24 1 136 10.1186/s12943‑025‑02305‑x 40336045
    [Google Scholar]
  28. Teillaud J.L. Houel A. Panouillot M. Riffard C. Dieu-Nosjean M.C. Tertiary lymphoid structures in anticancer immunity. Nat. Rev. Cancer 2024 24 9 629 646 10.1038/s41568‑024‑00728‑0 39117919
    [Google Scholar]
  29. Petitprez F. de Reyniès A. Keung E.Z. Chen T.W.W. Sun C.M. Calderaro J. Jeng Y.M. Hsiao L.P. Lacroix L. Bougoüin A. Moreira M. Lacroix G. Natario I. Adam J. Lucchesi C. Laizet Y. Toulmonde M. Burgess M.A. Bolejack V. Reinke D. Wani K.M. Wang W.L. Lazar A.J. Roland C.L. Wargo J.A. Italiano A. Sautès-Fridman C. Tawbi H.A. Fridman W.H. B cells are associated with survival and immunotherapy response in sarcoma. Nature 2020 577 7791 556 560 10.1038/s41586‑019‑1906‑8 31942077
    [Google Scholar]
  30. Zhang T. Li J. Yang M. Ma X. Wang Z. Ma X. Sun M. Sun W. Xu J. Hua Y. Cai Z. CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. Oncogene 2022 41 40 4524 4536 10.1038/s41388‑022‑02446‑z 36042349
    [Google Scholar]
  31. Zhang R. Zhang D. Han F. Song X. Zhang Y. Zhang J. Zhu Q. Qin Y. The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis. J. Exp. Clin. Cancer Res. 2024 43 1 135 10.1186/s13046‑024‑03056‑1 38702792
    [Google Scholar]
  32. Zhang H.T. Zeng Q. Wu B. Lu J. Tong K.L. Lin J. Liu Q.Y. Xu L. Yang J. Liu X. Liu W. Zhang Y.F. Lian Q. Liu L. Gao X. TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy. Cell Death Dis. 2021 12 1 21 10.1038/s41419‑020‑03364‑2 33414451
    [Google Scholar]
  33. Feng Z. Ke S. Wang C. Lu S. Xu Y. Yu H. Li Z. Yin B. Li X. Hua Y. Qian B. Bai M. Fu Y. Zhang Y. Wu Y. Ma Y. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. Oncogene 2023 42 24 2017 2030 10.1038/s41388‑023‑02710‑w 37142680
    [Google Scholar]
  34. Wei M. Mo Y. Liu J. Zhai J. Li H. Xu Y. Peng Y. Tang Z. Wei T. Yang X. Huang L. Shao X. Li J. Zhou L. Zhong H. Wei C. Xie Q. Min M. Wu F. Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation. Front. Oncol. 2022 12 835603 10.3389/fonc.2022.835603 35965501
    [Google Scholar]
  35. Liu Y. Xu G. Fu H. Li P. Li D. Deng K. Gao W. Shang Y. Wu M. Membrane-bound transcription factor LRRC4 inhibits glioblastoma cell motility. Int. J. Biol. Macromol. 2023 246 125590 10.1016/j.ijbiomac.2023.125590 37385320
    [Google Scholar]
  36. Feng J. Zhang Y. Ren X. Li D. Fu H. Liu C. Zhou W. Liu Q. Liu Q. Wu M. Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide. Oncogene 2020 39 23 4551 4566 10.1038/s41388‑020‑1312‑6 32372061
    [Google Scholar]
  37. Feng J. Ren X. Fu H. Li D. Chen X. Zu X. Liu Q. Wu M. LRRC4 mediates the formation of circular RNA CD44 to inhibit GBM cell proliferation. Mol. Ther. Nucleic Acids 2021 26 473 487 10.1016/j.omtn.2021.08.026 34631278
    [Google Scholar]
  38. Liu H. Heller-Trulli D. Moore C.L. Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration, invasion, and self-renewal. iScience 2022 25 8 104804 10.1016/j.isci.2022.104804 35992060
    [Google Scholar]
  39. Zhang Xuebin Wang Zengming Huang Shengsong He Dongyin Yan Weiwei Zhuang Qian Wang Zixian Wang Chenyang Tan Qilong Liu Ziqun Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer. J. Clin. Invest. 2023 133 24 e171199 10.1172/JCI171199 38099500
    [Google Scholar]
  40. Xie Y. Wang X. Wang W. Pu N. Liu L. Epithelial-mesenchymal transition orchestrates tumor microenvironment: Current perceptions and challenges. J. Transl. Med. 2025 23 1 386 10.1186/s12967‑025‑06422‑5 40176117
    [Google Scholar]
  41. Sannino G. Marchetto A. Kirchner T. Grünewald T.G.P. Epithelial-to-mesenchymal and mesenchymal-to-epithelial transition in mesenchymal tumors: A paradox in sarcomas? Cancer Res. 2017 77 17 4556 4561 10.1158/0008‑5472.CAN‑17‑0032 28811330
    [Google Scholar]
  42. Wang X.X. Liu Y.P. Lu Y. Wu L.H. Ren J.Y. Ji H. Wang X. Zhang H.M. Identifying specific TLS-associated genes as potential biomarkers for predicting prognosis and evaluating the efficacy of immunotherapy in soft tissue sarcoma. Front. Immunol. 2024 15 1372692 10.3389/fimmu.2024.1372692 38720884
    [Google Scholar]
  43. Liu J. Moura D.S. Jones R.L. Aggarwal A. Ebert P.J. Wagner A.J. Wright J. Martin-Broto J. Tap W.D. Best overall response–associated signature to doxorubicin in soft tissue sarcomas: A transcriptomic analysis from ANNOUNCE. Clin. Cancer Res. 2024 30 11 2598 2608 10.1158/1078‑0432.CCR‑23‑3936 38536068
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673388379251113061745
Loading
/content/journals/cmc/10.2174/0109298673388379251113061745
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.


  • Article Type:
    Research Article
Keywords: Sarcomas ; tumor microenvironment ; TCGA ; ubiquitination ; TRIM21 ; prognosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test